{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:04:08Z","timestamp":1778216648419,"version":"3.51.4"},"reference-count":20,"publisher":"BMJ","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.m3351","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T14:45:20Z","timestamp":1600181120000},"page":"m3351","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Painful perianal ulcers with nicorandil"],"prefix":"10.1136","author":[{"given":"Patricia","family":"McGettigan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin E","family":"Ferner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"2020091507450633000_370.sep15_4.m3351.1","unstructured":"Nicorandil. Summary of product characteristics. https:\/\/www.medicines.org.uk\/emc\/product\/9071\/smpc"},{"key":"2020091507450633000_370.sep15_4.m3351.2","doi-asserted-by":"publisher","DOI":"10.1097\/FAD.0000000000000014"},{"key":"2020091507450633000_370.sep15_4.m3351.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2018.01.004"},{"key":"2020091507450633000_370.sep15_4.m3351.4","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12147"},{"key":"2020091507450633000_370.sep15_4.m3351.5","doi-asserted-by":"publisher","DOI":"10.1308\/147870810X12699662981519"},{"key":"2020091507450633000_370.sep15_4.m3351.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"2020091507450633000_370.sep15_4.m3351.7","unstructured":"National Institute for Health and Care Excellence. Surveillance report (2016) Stable angina: management. 2011. https:\/\/www.nice.org.uk\/guidance\/cg126"},{"key":"2020091507450633000_370.sep15_4.m3351.8","unstructured":"Drugs.com. Nicorandil. 2020. https:\/\/www.drugs.com\/international\/nicorandil.html"},{"key":"2020091507450633000_370.sep15_4.m3351.9","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.031831"},{"key":"2020091507450633000_370.sep15_4.m3351.10","unstructured":"Medicines and Healthcare Products Regulatory Agency. Nicorandil (Ikorel): now second-line treatment for angina\u2014risk of ulcer complications. https:\/\/www.gov.uk\/drug-safety-update\/nicorandil-ikorel-now-second-line-treatment-for-angina-risk-of-ulcer-complications"},{"key":"2020091507450633000_370.sep15_4.m3351.11","unstructured":"New Zealand Medicines Safety Agency. Nicorandil\u2014updated indication and risk of ulcerations. 2017. https:\/\/www.medsafe.govt.nz\/profs\/PUArticles\/September2017\/Nicorandil.htm"},{"key":"2020091507450633000_370.sep15_4.m3351.12","unstructured":"Australian Government Department of Health Therapeutic Goods Authority. Nicorandil-associated ulceration. 2008. https:\/\/www.tga.gov.au\/publication-issue\/australian-adverse-drug-reactions-bulletin-vol-27-no-2#a1"},{"key":"2020091507450633000_370.sep15_4.m3351.13","unstructured":"World Health Organization . Nicorandil: use only as second line angina treatment. WHO Drug Inf 2016;30. https:\/\/www.who.int\/medicines\/publications\/druginformation\/WHO_DI_30-1_FullText.pdf?ua=1"},{"key":"2020091507450633000_370.sep15_4.m3351.14","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12845"},{"key":"2020091507450633000_370.sep15_4.m3351.15","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0294-9"},{"key":"2020091507450633000_370.sep15_4.m3351.16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1308\/147870810X12699662981113","article-title":"The role of nicorandil in non-healing surgical wounds","volume":"92","author":"Riddell","year":"2010","journal-title":"Ann R Coll Surg Engl"},{"key":"2020091507450633000_370.sep15_4.m3351.17","doi-asserted-by":"publisher","DOI":"10.1038\/srep11495"},{"key":"2020091507450633000_370.sep15_4.m3351.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2006.00972.x"},{"key":"2020091507450633000_370.sep15_4.m3351.19","unstructured":"European Medicines Regulatory . EudraVigilance. 2016. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/pharmacovigilance\/eudravigilance"},{"key":"2020091507450633000_370.sep15_4.m3351.20","doi-asserted-by":"publisher","DOI":"10.1308\/003588412X13171221501573"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.m3351","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.m3351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:09:24Z","timestamp":1601093364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.m3351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":20,"alternative-id":["10.1136\/bmj.m3351"],"URL":"https:\/\/doi.org\/10.1136\/bmj.m3351","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}